Investors Title Company
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- James Allen Fine
- Full Time Employees
- 561
- Sector
- Financial Services
- Industry
- Insurance - Specialty
- Address
- 121 North Columbia Street Chapel Hill NC United States of America 27514
- IPO Date
- Dec 3, 1986
- CIK
- 0000720858
- Website
- invtitle.com
- Similar Companies
- Business
- Investors Title Company, a holding company incorporated in North Carolina in 1973 and headquartered in Chapel Hill, North Carolina, primarily issues residential and commercial title insurance through its wholly owned underwriting subsidiaries, Investors Title Insurance Company (ITIC) and National Investors Title Insurance Company (NITIC); provides tax-deferred real property exchange services, including 1031 forward and reverse exchanges, through Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC); offers investment management and trust services to individuals, trusts, companies, banks, and other entities through Investors Trust Company; and delivers management services, consulting, escrow, settlement, and agency support to title insurance agencies via Investors Title Management Services (ITMS). ITIC and NITIC underwrite title insurance for owners and mortgagees as primary insurers, assume reinsurance risks from other title companies, and operate directly and through agents in 22 states and the District of Columbia, targeting residential, institutional, commercial, and industrial properties with ancillary offerings like EFLITE web-based applications for title reports and iTracs proprietary trust account management. The company, founded in 1972 by J. Allen Fine with ITIC operational since that year and NITIC since 1973, focuses on the title insurance industry with segments in property and casualty insurance, exchange services, and investment management. In recent developments, Investors Title reported record-breaking financial results in 2024 driven by title insurance revenue growth and market expansion, followed by strong third quarter 2025 performance with elevated title premiums, increased like-kind exchange activity, year-over-year volume gains across territories, and a robust open order pipeline amid declining mortgage rates; the board declared a special cash dividend of $8.72 per share alongside a regular quarterly dividend of $0.46 per share payable December 15, 2025; and North Carolina implemented title insurance rate changes effective October 1, 2025.
Company News
Investors Title (NASDAQ:ITIC) Reaches New 52-Week High – What’s Next?
Investors Title Company: Waiting For A Good Entry Point
Investors Title Q2 Earnings Rise Y/Y on Higher Title Activity
Investors Title Company Declares Quarterly Dividend
Investors Title Company Announces Second Quarter 2026 Results
Investors Title (NASDAQ:ITIC) Stock Passes Above 200-Day Moving Average – Here’s What Happened
ITIC vs DGICA: Which Insurance Stock is the Better Buy?
Investors Title Rises 22% in a Year: Should You Buy the Stock?
Investors Title Company Declares Quarterly Dividend
Investors Title's Q1 Earnings Soar Y/Y, Revenues Grow 13%
Investors Title Company Announces First Quarter 2026 Results
Investors Title: Still A Hold, Waiting For A Dip
ITIC Downgraded to Neutral on Housing Weakness Despite Premium Growth
Head-To-Head Review: Skyward Specialty Insurance Group (NASDAQ:SKWD) versus Investors Title (NASDAQ:ITIC)
Investors Title Company Declares Quarterly Dividend
Investors Title's Q4 Earnings Slump Y/Y Due to Lower Premium
Investors Title Company Announces Fourth Quarter and Fiscal Year 2025 Results
Investors Title (NASDAQ:ITIC) Shares Cross Above 200 Day Moving Average – Time to Sell?
Investors Title (NASDAQ:ITIC) Share Price Passes Above 200-Day Moving Average – Here’s What Happened
Investors Title Gains 22% in Six Months: Should You Buy the Stock?